glp-1 obesity drug news october 9 2025 Half of people stop taking popular weight-loss within a year, study finds Novo, Lilly weight-loss drugs should
Description
Market Share : North America and Europe collectively hold more than 70% of the market share, with the US holding the lions share
95% CI [0.760.94]) and HF hospitalisation (HR 0.92
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Metformin and tirzepatide together is a well-tolerated combination that many providers use for patients with type 2 diabetes
April 27, 2024
When sleep becomes disrupted, stress signaling through the braingut axis often increases, and sleep disturbance has been associated with worsening gastrointestinal symptoms
